Interventional Pulmonology Center, National Taiwan University Hospital, Hsin-Chu Branch, Hsinchu, Taiwan.
Department of Surgery, National Taiwan University Hospital, Hsin-Chu Branch, No. 2, Sec. 1, Shengyi Road, Zhubei, Hsinchu, 302, Taiwan.
Int J Comput Assist Radiol Surg. 2024 Nov;19(11):2203-2213. doi: 10.1007/s11548-024-03146-7. Epub 2024 May 2.
We developed a novel augmented fluoroscopy-guided intrathoracic stamping technique for localizing small pulmonary nodules in the hybrid operating room. We conducted an observational study to investigate the feasibility of this technique and retrospectively compared two augmented fluoroscopy-guided approaches: intrathoracic and transbronchial.
From August 2020 to March 2023, consecutive patients underwent single-stage augmented fluoroscopy-guided localization under general anaesthesia. This included intrathoracic stamping and bronchoscopic lung marking, followed by thoracoscopic resection in a hybrid operating room. Comparative analyses were performed between the two groups.
The data of 50 patients in the intrathoracic stamping and 67 patients in the bronchoscopic lung marking groups were analysed. No significant difference was noted in demographic data between the groups, except a larger lesion depth in the bronchoscopic lung marking group (14.7 ± 11.7 vs 11.0 ± 5.8 mm, p = 0.029). Dye localization was successfully performed in 49 intrathoracic stamping group patients (98.0%) and 67 bronchoscopic lung marking group patients (100%). No major procedure-related complications occurred in either group; however, the time flow (total anaesthesia time/global operating room time) was longer, and the radiation exposure (fluoroscopy duration/total dose area product) was larger in the bronchoscopic lung marking group.
Augmented fluoroscopic stamping localization under intubated general anaesthesia is feasible and safe, providing an alternative with less global operating room time and lower radiation exposure for image-guided thoracoscopic surgery in the hybrid operating room.
我们开发了一种新的增强透视引导下经胸内标记技术,用于定位杂交手术室中的小肺结节。我们进行了一项观察性研究,以调查该技术的可行性,并回顾性比较了两种增强透视引导方法:经胸内和经支气管。
从 2020 年 8 月至 2023 年 3 月,连续患者在全身麻醉下接受单阶段增强透视引导定位。这包括经胸内标记和支气管镜下肺标记,然后在杂交手术室进行胸腔镜切除。对两组进行了比较分析。
分析了经胸内标记组 50 例患者和支气管镜肺标记组 67 例患者的数据。两组患者的人口统计学数据无显著差异,但支气管镜肺标记组的病变深度更大(14.7±11.7 与 11.0±5.8,p=0.029)。在经胸内标记组的 49 例患者(98.0%)和支气管镜肺标记组的 67 例患者(100%)中成功进行了染料定位。两组均未发生重大手术相关并发症;然而,支气管镜肺标记组的时间流程(总麻醉时间/全球手术室时间)较长,辐射暴露(透视时间/总剂量面积产品)较大。
在插管全身麻醉下进行增强透视标记定位是可行且安全的,为杂交手术室中的影像引导胸腔镜手术提供了一种替代方法,可减少全球手术室时间和降低辐射暴露。